Eurobio Scientific: CNR validation of two COVID-19 serology tests

NEXT STORY
Insights on the Worldwide Companion Diagnostic Industry to 2024 – by Funding Source & Application
PREV STORY
ERYTECH Provides Update on Phase 2 Investigator Sponsored Trial of Eryaspase in Second-Line Acute Lymphoblastic Leukemia
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

VBI Vaccines Announces Voluntary Delisting from the Toronto Stock Exchange

CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. ("VBI" or the ...

author_avatar
NASDAQ Market News

Calithera Biosciences Appoints Suzy Jones to Board of Directors

SOUTH SAN FRANCISCO, Calif., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

FIT Biotech Oy Company release April 7, 2017 at 10:00 EET Conversion of FIT ...

author_avatar
NASDAQ Market News